Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 10, 2026
MP Materials (MP) and USA Rare Earth (USAR): Examining Two Key Players in U.S. Rare Earth Supply Chains

MP Materials (MP) and USA Rare Earth (USAR): Examining Two Key Players in U.S. Rare Earth Supply Chains

Key Takeaways

  • Both MP and USAR operate in the rare earth materials sector, positioning them as key players in U.S. efforts to reduce reliance on foreign supply chains for critical minerals used in electric vehicles, renewables, and defense applications.
  • MP benefits from established production at its Mountain Pass facility, while USAR focuses on vertical integration including mining, processing, and magnet manufacturing with recent expansion moves.
  • Recent market activity shows both stocks experiencing volatility tied to commodity prices, policy developments, and sector sentiment, with relative performance reflecting differences in operational scale and project timelines.
  • MP offers exposure to neodymium-praseodymium (NdPr) production, whereas USAR emphasizes heavy rare earth elements and domestic magnet capabilities.
  • Risk factors for both include commodity price fluctuations, execution on expansion projects, and broader economic conditions affecting demand for rare earth-dependent technologies.
  • Market sentiment for the pair remains influenced by U.S. government initiatives supporting domestic critical minerals production.

Why MP and USAR Stand Out

MP Materials Corp. (MP) and USA Rare Earth, Inc. (USAR) represent two publicly traded companies advancing rare earth material supply chains within the United States. Investors and traders focused on critical minerals, clean energy transition themes, or domestic manufacturing resilience may find this comparison relevant. The analysis examines business models, recent price behavior, and relative positioning to provide a factual overview of how these stocks have performed amid evolving market conditions.

MP Materials: Established Production at Mountain Pass

MP Materials Corp. produces rare earth materials, primarily through its Mountain Pass mine and processing facility in California. The company operates in materials and magnetics segments, with output centered on elements such as neodymium-praseodymium (NdPr) used in permanent magnets. In recent weeks, the stock has reflected broader sector movements driven by rare earth price trends and policy support for U.S. production. Market activity indicates sensitivity to global supply dynamics and demand from electric vehicle and renewable energy sectors, contributing to observed volatility without establishing directional trends. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

USA Rare Earth: Building a Vertically Integrated Operation

USA Rare Earth, Inc. develops a vertically integrated domestic supply chain for rare earth magnets and heavy rare earth elements, including assets such as the Round Top deposit in Texas. The company has pursued expansion through acquisitions and processing capabilities. Recent market activity shows price movements aligned with sector sentiment and company-specific developments related to project advancement. Performance has been influenced by progress on mining rights, processing infrastructure, and integration strategies, resulting in fluctuations consistent with early-stage resource development profiles.

Head-to-Head: MP vs USAR

MP Materials Corp. (MP) maintains an established production base focused on light rare earth elements, offering scale advantages in current output compared to USA Rare Earth, Inc. (USAR), which emphasizes heavy rare earths and full vertical integration from mine to magnet. Growth drivers differ: MP benefits from existing infrastructure, while USAR pursues acquisitions to accelerate capabilities. Recent momentum for both has been shaped by rare earth market conditions, though MP exhibits characteristics of a more mature operator versus USAR’s development-stage profile. Risk factors include commodity price exposure for each, with USAR carrying additional execution risks tied to project timelines. Sector exposure centers on critical minerals for both, with market sentiment responsive to U.S. policy initiatives. Trade-offs involve MP’s production stability versus USAR’s potential for broader supply chain control. From what I see, the differences in maturity stand out clearly here.

AI-Assisted Perspective on the Pair

Based on observable factors such as trend consistency, operational stability, and relative positioning within the rare earth sector, Tickeron’s AI would currently assign a probabilistic preference toward MP due to its established production profile and lower near-term execution variability compared to USAR. This assessment reflects measurable differences in current output capacity and project maturity rather than definitive forecasts. I’m watching this closely as policy support continues to evolve.

Using AI Trading Bots for Sector Analysis

In evaluating names like these, I’ve turned to Tickeron’s AI Trading Bots for additional perspective on how automated strategies align with current sector trends. The platform offers hundreds of bots across varied styles, timeframes, and tickers, with historical performance metrics and win rates highlighted to help assess fit for different risk levels. It’s one way I supplement traditional research when comparing emerging opportunities in critical minerals.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MP, USAR

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


MP's RSI Indicator ascending out of oversold territory

The RSI Indicator for MP moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In of the 31 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 04, 2026. You may want to consider a long position or call options on MP as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MP just turned positive on August 03, 2026. Looking at past instances where MP's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MP advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

MP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 50-day moving average for MP moved below the 200-day moving average on July 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MP entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.649) is normal, around the industry mean (11.557). MP's P/E Ratio (770.500) is considerably higher than the industry average of (130.643). MP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.295). MP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.025). P/S Ratio (29.674) is also within normal values, averaging (294.079).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are BHP Group Limited (NYSE:BHP), Vale SA (NYSE:VALE).

Industry description

The category includes companies that explore for, mine and extract metals, such as copper, diamonds, nickel, cobalt ore, lead, zinc and uranium. BHP, Rio Tinto and Southern Copper Corporation are major players in this space.

Market Cap

The average market capitalization across the Other Metals/Minerals Industry is 9.45B. The market cap for tickers in the group ranges from 230 to 225B. BHP holds the highest valuation in this group at 225B. The lowest valued company is BAJFF at 230.

High and low price notable news

The average weekly price growth across all stocks in the Other Metals/Minerals Industry was 17%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was -17%. WWR experienced the highest price growth at 86%, while EMAT experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Other Metals/Minerals Industry was 176%. For the same stocks of the Industry, the average monthly volume growth was 102% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 78
Price Growth Rating: 56
SMR Rating: 92
Profit Risk Rating: 87
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
MP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry OtherMetalsMinerals

Profile
Details
Industry
N/A
Address
1700 S. Pavilion Center Drive, 8th Floor
Phone
+1 702 844-6111
Employees
681
Web
https://www.mpmaterials.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.